Related references
Note: Only part of the references are listed.Trigonelline inhibits Nrf2 via EGFR signalling pathway and augments efficacy of Cisplatin and Etoposide in NSCLC cells
Chandrani Fouzder et al.
TOXICOLOGY IN VITRO (2021)
PAQR4 promotes chemoresistance in non-small cell lung cancer through inhibiting Nrf2 protein degradation
Peifang Xu et al.
THERANOSTICS (2020)
Digoxin sensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine via inhibiting Nrf2 signaling pathway
Yunjiang Zhou et al.
REDOX BIOLOGY (2019)
High NRF2 expression controls endoplasmic reticulum stress induced apoptosis in multiple myeloma
Yu Sun et al.
CANCER LETTERS (2018)
Kaempferol Induces G2/M Cell Cycle Arrest via Checkpoint Kinase 2 and Promotes Apoptosis via Death Receptors in Human Ovarian Carcinoma A2780/CP70 Cells
Ying Gao et al.
MOLECULES (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Structural instability of I kappa B kinase beta promotes autophagic degradation through enhancement of Keap1 binding
Mayu Kanamoto et al.
PLOS ONE (2018)
Kaempferol Inhibits the Invasion and Migration of Renal Cancer Cells through the Downregulation of AKT and FAK Pathways
Tung-Wei Hung et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2017)
Kaempferol induces autophagic cell death of hepatocellular carcinoma cells via activating AMPK signaling
Bing Han et al.
ONCOTARGET (2017)
Palmitate induced Fetuin-A secretion from pancreatic β-cells adversely affects its function and elicits inflammation
Alpana Mukhuty et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Kaempferol inhibits the growth and metastasis of cholangiocarcinoma in vitro and in vivo
Youyou Qin et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2016)
The Nrf2/HO-1 Axis in Cancer Cell Growth and Chemoresistance
A. L. Furfaro et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
Prognostic significance of FoxM1 expression in non-small cell lung cancer
Qing Sun et al.
JOURNAL OF THORACIC DISEASE (2016)
Dissecting molecular cross-talk between Nrf2 and NF-kappa B response pathways
Joanna D. Wardyn et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2015)
Inhibitory Effects of Isorhamnetin on the Invasion of Human Breast Carcinoma Cells by Downregulating the Expression and Activity of Matrix Metalloproteinase-2/9
Chenglin Li et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2015)
Kaempferol suppresses bladder cancer tumor growth by inhibiting cell proliferation and inducing apoptosis
Qiang Dang et al.
MOLECULAR CARCINOGENESIS (2015)
Kaempferol inhibits gastric cancer tumor growth: An in vitro and in vivo study
Haibin Song et al.
ONCOLOGY REPORTS (2015)
Luteolin inhibits the Nrf2 signaling pathway and tumor growth in vivo
Song Chian et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Inhibition of NRF2 by PIK-75 augments sensitivity of pancreatic cancer cells to gemcitabine
Hong-Quan Duong et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention
Allen Y. Chen et al.
FOOD CHEMISTRY (2013)
Kaempferol Reduces Matrix Metalloproteinase-2 Expression by Down-Regulating ERK1/2 and the Activator Protein-1 Signaling Pathways in Oral Cancer Cells
Chiao-Wen Lin et al.
PLOS ONE (2013)
Anti-cancer Effect and Underlying Mechanism(s) of Kaempferol, a Phytoestrogen, on the Regulation of Apoptosis in Diverse Cancer Cell Models
Seung-Hee Kim et al.
TOXICOLOGICAL RESEARCH (2013)
Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance
Durba Pal et al.
NATURE MEDICINE (2012)
Carlinoside reduces hepatic bilirubin accumulation by stimulating bilirubin-UGT activity through Nrf2 gene expression
Rakesh Kundu et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Luteolin inhibits Nrf2 leading to negative regulation of the Nrf2/ARE pathway and sensitization of human lung carcinoma A549 cells to therapeutic drugs
Xiuwen Tang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution
Keiko Taguchi et al.
GENES TO CELLS (2011)
Genetic Disruption of KEAP1/CUL3 E3 Ubiquitin Ligase Complex Components is a Key Mechanism of NF-KappaB Pathway Activation in Lung Cancer
Kelsie L. Thu et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism
Dongmei Ren et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Oxidative stress in non-small cell lung cancer patients after chemotherapy: Association with treatment response
Abhilasha Gupta et al.
RESPIROLOGY (2010)
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009
G. Kroemer et al.
CELL DEATH AND DIFFERENTIATION (2009)
KEAP1 E3 Ligase-Mediated Downregulation of NF-κB Signaling by Targeting IKKβ
Dung-Fang Lee et al.
MOLECULAR CELL (2009)
Identification of retinoic acid as an inhibitor of transcription factor Nrf2 through activation of retinoic acid receptor alpha
Xiu Jun Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Mechanistic studies of the Nrf2-Keap1 signaling pathway
Donna D. Zhang
DRUG METABOLISM REVIEWS (2006)
Kaempferol-induced growth inhibition and apoptosis in A549 lung cancer cells is mediated by activation of MEK-MAPK
TTT Nguyen et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2003)
Share Paper
